Telik Announces Presentation and Webcast at UBS Global Life Sciences Conference

Thursday, September 18, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

PALO ALTO, Calif., Sept. 17 Telik, Inc.(Nasdaq: TELK) announced that company management will provide a corporateoverview at the UBS Global Life Sciences Conference in New York City onWednesday, September 24, 2008 at 9:30 a.m. Eastern time (6:30 a.m. Pacifictime). Telik's presentation will be webcast live and will be available forreplay through the Telik website, http://www.telik.com, through October 25,2008.

Telik, Inc. of Palo Alto, CA, is a biopharmaceutical company focused ondiscovering, developing and commercializing novel small molecule drugs totreat serious diseases. The company's most advanced investigational drugcandidates in clinical development are TELINTRA(R), a modified glutathioneanalog for the treatment of cytopenias due to myelodysplastic syndrome orchemotherapy, and TELCYTA(R), a tumor-activated prodrug for the treatment ofadvanced ovarian cancer and non-small cell lung cancer. Telik's productcandidates were discovered using its proprietary drug discovery technology,TRAP(R), which enables the rapid and efficient discovery of small moleculedrug candidates.

TELIK, the Telik logo, TELINTRA, TELCYTA, and TRAP are trademarks orregistered trademarks of Telik, Inc.

SOURCE Telik, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook